Conditions : Knee Cartilage Defects; Osteoarthritis Intervention : Biological: Bone marrow derived mesenchymal stem cells Sponsors : Royan Institute; Tehran University of Medical Sciences Completed -...

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Completed - verified September 2013

Condition : Rheumatoid Arthritis Interventions : Biological: Phase 1: Etanercept; Drug: Phase 1: Methotrexate; Drug: Phase 2: Optional ETN, SSZ, HCQ, MTX; Drug: Phase 1: Methotrexate; Drug: Phase 1: C...

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: rituximab [MabThera/Rituxan]; Drug: Placebo Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Completed - ve...

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: rituximab [MabThera/Rituxan]; Drug: Placebo Sponsor : Hoffmann-La Roche Active, not recruiting - verified...

Condition : Arthritis, Rheumatoid Interventions : Drug: CP-690,550; Drug: CP-690,550; Drug: CP-690,550; Drug: CP-690,550; Drug: Placebo; Drug: CP-690,550; Drug: Placebo; Drug: CP-690,550 Sponsor : Pfi...

Condition : Arthritis, Rheumatoid Interventions : Drug: CP-690,550; Drug: CP-690,550; Drug: CP-690,550; Drug: CP-690,550; Drug: Placebo; Drug: CP-690,550; Drug: Placebo; Drug: CP-690,550 Sponsor : Pfi...

Condition : Rheumatoid Arthritis Interventions : Drug: Placebo; Drug: dose level 1; Drug: dose level 2; Drug: dose level 3; Drug: dose level 4 Sponsor : Pfizer Active, not recruiting - verified July 2...

Condition : Rheumatoid Arthritis Interventions : Drug: Placebo; Drug: dose level 1; Drug: dose level 2; Drug: dose level 3; Drug: dose level 4 Sponsor : Pfizer Active, not recruiting - verified August...

Condition : Arthritis Interventions : Device: Bone cement 1; Device: Bone cement 2 Sponsors : Norwegian University of Science and Technology; DePuy International Completed - verified August 2011